Research Topics
Genomes and Genes | Par StattinSummaryCountry: Sweden Publications
| Collaborators
|
Detail Information
Publications
Long-term outcome of conservative therapy in men presenting with voiding symptoms and prostate cancerP Stattin
Department of Urology, Umea University, Sweden
Eur Urol 32:404-9. 1997..To investigate the outcome of conservative therapy in men presenting with voiding symptoms and prostate cancer...
High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective studyPar Stattin
Department of Urology, Umea University Hospital, Umea, Sweden
Int J Cancer 108:418-24. 2004..bottom quintile of 0.82 (95% CI = 0.60-1.14; p(trend) = 0.44). No support was found for the hypothesis that high levels of circulating androgens within a physiologic range stimulate development and growth of prostate cancer...
Plasma leptin and colorectal cancer risk: a prospective study in Northern SwedenPar Stattin
Department of Urology, Umea University Hospital, 901 85 Umea, Sweden
Oncol Rep 10:2015-21. 2003..I.=0.72-5.29), whereas no increase was seen for rectal cancer. In women, no association between leptin and risk was seen. These data support the hypothesis that leptin is a risk marker for colorectal cancer in men, but not in women...
Obesity and colon cancer: does leptin provide a link?Par Stattin
Department of Urology and Andrology, Umea University Hospital, Umea, Sweden
Int J Cancer 109:149-52. 2004..Leptin may be directly involved in colon tumorigenesis or it may serve as a sensitive and robust marker of an obesity-induced adverse endocrine environment. Only weak support for an association of insulin with colon cancer was found...
High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohortPar Stattin
Department of Surgery and Perioperative Sciences, Urology and Andrology, Umea University Hospital, 901 85 Umea, Sweden
J Clin Oncol 22:3104-12. 2004..Insulin-like growth factor-I (IGF-I) stimulates proliferation and inhibits apoptosis in prostate cancer cells, and IGF-I has been associated with increased prostate cancer risk in some, but not all, epidemiologic studies...
Plasma leptin is not associated with prostate cancer riskPar Stattin
Department of Urology and Andrology, Umea University Hospital, 901 85 Umea, Sweden
Cancer Epidemiol Biomarkers Prev 12:474-5. 2003
Prospective study of plasma enterolactone and prostate cancer risk (Sweden)Par Stattin
Department of Surgery and Perioperative Sciences, Urology and Andrology, Umed University Hospital, Sweden
Cancer Causes Control 15:1095-102. 2004..We studied the association between plasma enterolactone and risk of prostate cancer...
Geographical variation in incidence of prostate cancer in SwedenPar Stattin
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University Hospital, Umea, Sweden
Scand J Urol Nephrol 39:372-9. 2005..To investigate the geographical variation in prostate cancer incidence in Sweden, in particular the incidences of screening-detected tumours and curative treatment of prostate cancer...
Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up studyPar Stattin
Urology and Andrology, Department of Surgical and Perioperative Science, Umea University Hospital, Umea, Sweden
J Natl Cancer Inst 102:950-8. 2010..To our knowledge, there are no outcome studies from contemporary population-based cohorts that include data on stage, Gleason score, and serum levels of prostate-specific antigen (PSA)...
Ratios of IGF-I, IGF binding protein-3, and prostate-specific antigen in prostate cancer detectionP Stattin
Department of Urology and Andrology, Umea University Hospital, 901 85 Umea, Sweden
J Clin Endocrinol Metab 86:5745-8. 2001..It is unlikely that these combinations will improve prostate cancer detection...
Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer RegistryPar Stattin
Department of Urology and Andrology, Umea University Hospital, Umea, Sweden
Scand J Urol Nephrol 37:461-5. 2003..The aim of this study was to investigate the cause of initiating a work-up leading to a diagnosis of prostate cancer, with emphasis on T1c tumours...
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective studyP Stattin
Department of Urology and Andrology, Umea University Hospital, Sweden
J Natl Cancer Inst 92:1910-7. 2000..In this study, we sought to determine the role of IGF-I as well as IGFBPs-1, -2, and -3 and insulin as possible etiologic factors for prostate cancer...
Plasma prolactin and prostate cancer risk: A prospective studyP Stattin
Department of Urology and Andrology, Umea University Hospital, Umea, Sweden
Int J Cancer 92:463-5. 2001..Elevated circulating levels of prolactin were not related to an increase in prostate cancer risk, indicating that high circulating prolactin is not associated with development of prostate cancer...
Prospective study of hyperglycemia and cancer riskPar Stattin
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University Hospital, 901 85 Umea, Sweden
Diabetes Care 30:561-7. 2007..To investigate whether hyperglycemia is associated with increased cancer risk...
Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of SwedenPar Stattin
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
J Urol 180:2423-9; discussion 2429-30. 2008..To what extent active surveillance and deferred treatment for localized risk prostate cancer are used is unclear. We assessed the use of surveillance and of deferred treatment in a population based, nationwide cohort in Sweden...
Circulating insulin-like growth factor-I and benign prostatic hyperplasia--a prospective studyP Stattin
Department of Urology and Andrology, Umea University Hospital, Sweden
Scand J Urol Nephrol 35:122-6. 2001..The IGFBPs regulate the efflux of IGF-I to the extravascular space and the bioavailability of IGF-I within tissues...
Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levelsMattias Johansson
Department of Surgical and Perioperative Sciences, Umea University Hospital, 901 85 Umea, Sweden
J Clin Endocrinol Metab 92:4820-6. 2007..We recently found a haplotype in the 3' region of the IGF-I gene associated with increased risk of prostate cancer, and we hypothesized that the observed association is mediated by circulating IGF-I...
Insulin resistance is inversely related to prostate cancer: a prospective study in Northern SwedenTanja Stocks
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University Hospital, Umea, Sweden
Int J Cancer 120:2678-86. 2007..Our data suggest that androgens, which are inversely associated with insulin resistance, are important in the early prostate cancer development, whereas insulin resistance related factors may be important for tumour progression...
Prospective study on metabolic factors and risk of prostate cancerChristel Häggström
Department of Surgical and Perioperative Sciences, Umea University Hospital, Umea University, Umea, Sweden
Cancer 118:6199-206. 2012..There are inconsistent data regarding the association between metabolic factors, separately and combined, and the risk of prostate cancer and death from prostate cancer...
Circulating enterolactone and prostate cancer risk: a Nordic nested case-control studyPar Stattin
Department of Urology, Umea University Hospital, Umea, Sweden
Int J Cancer 99:124-9. 2002..21 (95% CI = 0.91-1.60), 1.02 (95% CI = 0.59-1.76) and 0.87 (95% CI = 0.45-1.67), respectively. No support for the hypothesis that high circulating enterolactone is protective against prostate cancer was found...
Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer ProjectTanja Stocks
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
Hypertension 59:802-10. 2012..12 (95% CI: 1.08-1.15) for men and 1.06 (95% CI: 1.02-1.11) for women. These results suggest a small increased cancer risk overall in men with elevated blood pressure level and a higher risk for cancer death in men and women...
Effects of prostate-specific antigen testing on familial prostate cancer risk estimatesOla Bratt
Department of Urology, Helsingborg Hospital, Helsingborg, Sweden
J Natl Cancer Inst 102:1336-43. 2010..Family history is a strong risk factor for prostate cancer. The aim of this study was to investigate whether increased diagnostic activity is related to the incidence of prostate cancer among brothers of men with prostate cancer...
Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancerMattias Johansson
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University Hospital, Umea, Sweden
Int J Cancer 120:539-42. 2007..Further studies on genetic variations in the IGF1 gene in relation to prostate cancer risk as well as to circulating levels of IGF1 are needed to confirm this novel finding...
The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survivalEberhard Varenhorst
Department of Urology, Faculty of Health Sciences, University Hospital Linkoping, Linkoping, Sweden
Scand J Urol Nephrol 39:117-23. 2005..To provide a descriptive review of the establishment of the National Prostate Cancer Register (NPCR) in Sweden, to present clinical characteristics at diagnosis and to calculate the relative survival of different risk groups after 5 years...
Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern SwedenBjörn Pilebro
Department of Urology, Umea University Hospital, Sweden
Scand J Urol Nephrol 37:210-2. 2003..The aim of this study was to investigate the pattern of PSA testing in clinical practice for men diagnosed with stage T1c prostate cancer in a region with no formal screening programme...
Plasma leptin and breast cancer risk: a prospective study in northern SwedenPar Stattin
Department of Urology and Andrology, Umea University Hospital, Umea, Sweden
Breast Cancer Res Treat 86:191-6. 2004..Obesity is associated with risk of breast cancer after menopause. Circulating levels of leptin are high in obesity and leptin stimulates growth of breast cancer cells...
Estrogen receptor beta polymorphism is associated with prostate cancer riskCamilla Thellenberg-Karlsson
Department of Radiation Sciences Oncology, University of Umea, Umea, Sweden
Clin Cancer Res 12:1936-41. 2006..ERbeta is thought to exert an antiproliferative and proapoptotic effect. We examined whether sequence variants in the ERbeta gene are associated with prostate cancer risk...
Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4Lina Thors
Pharmacology Unit, Department of Pharmacology and Clinical Neuroscience, Umea University, Umea, Sweden
PLoS ONE 5:e12275. 2010....
Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcomeAndreas Josefsson
Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden
Am J Pathol 179:1961-8. 2011..In conclusion, cancer in the prostate apparently stimulates HA synthesis both in tumor stroma and in the surrounding normal tissue. This promoted tumor growth and was associated with an unfavorable outcome...
Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of SwedenOla Bratt
Department of Urology, Helsingborg Hospital, Lund University, Sweden
Scand J Urol Nephrol 44:384-90. 2010..To investigate the effects of prostate-specific antigen (PSA) testing of men without clinical signs of prostate cancer on the incidence of prostate cancer in Sweden...
Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancerFredrik Lindmark
Department of Radiation Sciences, Oncology, University of Umea, Umea, Sweden
Prostate 59:132-40. 2004..Here, we further elucidate the role of MSR1 in both Swedish families with HPC and in a cohort of unselected prostate cancer...
Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survivalEmma Hörnberg
Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden
PLoS ONE 6:e19059. 2011....
Inherited variation in hormone-regulating genes and prostate cancer survivalSara Lindstrom
Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
Clin Cancer Res 13:5156-61. 2007..However, little is known about genetic determinants of disease progression and prostate cancer-specific death...
Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapyPernilla Wikstrom
Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden
Prostate 67:1277-84. 2007....
The MTHFR 677C --> T polymorphism and risk of prostate cancer: results from the CAPS studyMattias Johansson
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University Hospital, Umea 901 85, Sweden
Cancer Causes Control 18:1169-74. 2007..In conclusion, our results do not provide strong support for the hypothesis that the MTHFR 677C-->T polymorphism is related to prostate cancer risk...
PCBaSe Sweden: a register-based resource for prostate cancer researchEva Hagel
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
Scand J Urol Nephrol 43:342-9. 2009..Many topics in clinical prostate cancer epidemiology can be investigated. using PCBaSe Sweden...
The UGT2B17 gene deletion is not associated with prostate cancer riskMats Olsson
Department of Urology, Karolinska University Hospital, Stockholm, Sweden
Prostate 68:571-5. 2008..Here we determine the risk in a large-scale population-based case-control study...
Genetic variation in the upstream region of ERG and prostate cancerSara Lindstrom
Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
Cancer Causes Control 20:1173-80. 2009..Here, we investigated if inherited genetic variation upstream of ERG alters prostate cancer risk and survival...
Androgens and prostate cancer risk: a prospective studySara Wirén
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
Prostate 67:1230-7. 2007..However, some recent studies have shown that a high level of testosterone increase the risk of non-aggressive tumors but is associated with a decreased risk of aggressive tumors...
Nationwide population-based study on 30-day mortality after radical prostatectomy in SwedenSigrid Carlsson
Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
Scand J Urol Nephrol 43:350-6. 2009..Radical prostatectomy (RP) is currently commonly performed, either within or outside large high-volume centres. The aim of this study was to assess the 30-day mortality rate after RP in Sweden...
Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillanceAndreas Josefsson
Department of Medical Biosciences, Pathology, Umea University, Sweden
Scand J Urol Nephrol 46:247-57. 2012..The aim of this study was to explore whether vascular density and tumour cell proliferation are related to the risk of prostate cancer death in patients managed by watchful waiting...
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe SwedenDavid Robinson
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Sweden
Int J Cancer 130:478-87. 2012..Our data underline the importance of a proper indication for ET because many men with low-risk prostate cancer currently receive ET...
-160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancerBjörn Anders Jonsson
Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden
Int J Cancer 109:348-52. 2004..6; 95% CI = 1.4-4.9). Our data indicate that the -160 single nucleotide polymorphism in CDH1 is a low-penetrant prostate cancer susceptibility gene that might explain a proportion of familial and notably hereditary prostate cancer...
Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patientsPeter Hammarsten
Departments of Medical Biosciences, Pathology and Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
Clin Cancer Res 16:1245-55. 2010..To explore if the expression of phosphorylated epidermal growth factor receptor (pEGFR) in nonmalignant and malignant prostate tissue is a potential prognostic marker for outcome in prostate cancer patients...
Psychiatric treatment in men with prostate cancer--results from a Nation-wide, population-based cohort study from PCBaSe SwedenAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
Eur J Cancer 47:2195-201. 2011..To explore whether the self-reported psychological distress among men with prostate cancer was to the extent that it required psychiatric treatment...
H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancerFredrik Lindmark
Department of Radiation Sciences Oncology, Umea University, Umea, Sweden
J Natl Cancer Inst 96:1248-54. 2004..We examined whether sequence variants in the MIC-1 gene are associated with the risk of prostate cancer...
Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expressionPeter Hammarsten
Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden
PLoS ONE 7:e47994. 2012....
Metabolic factors associated with risk of renal cell carcinomaChristel Häggström
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
PLoS ONE 8:e57475. 2013..High levels of BMI, blood pressure, glucose and triglycerides among men and high BMI among women were associated with increased risk of RCC...
Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can)Christel Häggström
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
Int J Cancer 128:1890-8. 2011..Hypertension and a composite MetS score were significantly but modestly associated with an increased risk of bladder cancer among men and elevated glucose was associated with a nonsignificant increase in risk among women...
Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patientsPernilla Wikstrom
Departments of Medical Biosciences, Pathology, Umea University, Umea, Sweden
Prostate 69:799-809. 2009..The role of androgen receptors (ARs) in the prostate tumor cell environment is largely unknown...
Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterolElin Thysell
Department of Chemistry, Umea University, Umea, Sweden
PLoS ONE 5:e14175. 2010..Identification of metabolic pathways involved in the growth of bone metastases therefore has the potential to improve PCa prognostication as well as therapy...
Rye, lignans and human healthGoran Hallmans
Departments of Public Health and Clinical Medicine, University of Umea, Umea, Sweden
Proc Nutr Soc 62:193-9. 2003..It seems reasonable to assume that these protective effects are associated with one or more factors in the dietary fibre complex...
Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition studyMattias Johansson
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, 901 85 Umea, Sweden
Cancer Epidemiol Biomarkers Prev 17:279-85. 2008..The aim of the present study was to investigate the relationship between prostate cancer risk and circulating concentrations of folate and vitamin B(12) in a large prospective cohort...
The magnitude of early castration-induced primary tumour regression in prostate cancer does not predict clinical outcomeNina Ohlson
Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden
Eur Urol 49:675-83. 2006..This study was designed to test whether early castration-induced short-term cellular changes in primary prostate tumours could predict clinical outcome in advanced disease...
Castration-induced epithelial cell death in human prostate tissue is related to locally reduced IGF-1 levelsNina Ohlson
Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden
Prostate 67:32-40. 2007..Castration rapidly reduces stroma insulin-like growth factor (IGF)-1 synthesis and action in mouse prostate epithelium. We explore if similar changes are of importance for castration-induced prostate regression in humans...
Leptin is associated with increased prostate cancer risk: a nested case-referent studyP Stattin
Department of Urology, , , Sweden
J Clin Endocrinol Metab 86:1341-5. 2001..A critical fat mass related to an interior milieu favorable for prostate cancer development seems to exist, because intermediate but not high leptin levels are related to prostate cancer risk...
LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancerMarcus Thomasson
Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
Int J Cancer 128:2843-52. 2011..We propose that LRIG1 is an important determinant of prostate cancer growth, and the implications of its expression on patient outcome depend on the clinical and biological circumstances...
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohortsTanja Stocks
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
PLoS Med 6:e1000201. 2009..We examined the association between blood glucose and cancer risk in a prospective study of six European cohorts...
Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphataseDavid Robinson
Department of Urology, Ryhov County Hospital, Jonkoping, Sweden
J Urol 179:117-22; discussion 122-3. 2008..We determined how serial measurements of prostate specific antigen and alkaline phosphatase can be used to predict survival early in the course of hormone treated metastatic prostate cancer...
SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancerAsa Skytt
Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden
Int J Cancer 121:615-20. 2007....
A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancerSui Chu Chung
Department of Pharmacology and Clinical Neuroscience, Pharmacology, Umea University, Umea, Sweden
Eur J Cancer 45:174-82. 2009..It is concluded that a high tumour CB(1)IR score is associated with prostate cancer severity and outcome...
Rye bran diet increases epithelial cell apoptosis and decreases epithelial cell volume in TRAMP (transgenic adenocarcinoma of the mouse prostate) tumorsPernilla Wikstrom
Department of Medical Biosciences, Pathology, Umea University, Sweden
Nutr Cancer 53:111-6. 2005..There were, however, no significant changes detected in lobe weights or tumor grade. In conclusion, a rye bran diet increases epithelial apoptosis and reduces the epithelial cell fraction in TRAMP tumors...
Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapyAnna Johansson
Department of Medical Biosciences, Umea University, Umea, Sweden
Am J Pathol 177:1031-41. 2010..In addition, peritumoral mast cells provide FGF-2 to the tumor micro environment, which may contribute to their stimulating effect on angiogenesis...
MRI of the skeleton in prostate cancer stagingAnders Rydh
Department of Diagnostic Radiology, Umea University, Sweden
Scand J Urol Nephrol 37:222-5. 2003..To explore the value of MRI in the detection of bone metastases in newly diagnosed prostate cancer...
Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumorsSofia Halin
Department of Medical Biosciences, Umea University, Umea, Sweden
Cancer Res 64:5664-71. 2004..These observations indicate that loss of pigment epithelium-derived factor expression could be associated with the progression toward a metastatic phenotype in prostate cancer...
Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe SwedenAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
Eur Urol 57:390-5. 2010..The risk of suicide is increased among cancer patients including men with prostate cancer (PCa). However, whether this increased risk applies to men diagnosed subsequent to prostate-specific antigen (PSA) testing is not known...
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5Per Olov Hedlund
Department of Urology, Karolinska University Hospital Solna, Sweden
Scand J Urol Nephrol 42:220-9. 2008..The aim of the study was to compare anticancer efficacy and adverse events, especially cardiovascular events...
Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohortTanja Stocks
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
Int J Cancer 127:1660-8. 2010..Our study support a positive association between overweight and risk of fatal prostate cancer...
Components of the metabolic syndrome and colorectal cancer risk; a prospective studyT Stocks
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University Hospital, Umea, Sweden
Int J Obes (Lond) 32:304-14. 2008..To examine the relation of well-known factors of the metabolic syndrome (MetS) as well as related circulating factors, with risk of colorectal cancer...
p53 expression in correlation to clinical outcome in patients with renal cell carcinomaB Ljungberg
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Sweden
Scand J Urol Nephrol 35:15-20. 2001..The aim of this study was to evaluate the role of p53 as prognostic factor in renal cell carcinoma (RCC) and its relation to clinicopathological factors...
Androgens and prostate cancer riskSara Wirén
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, SE 901 85 Umea, Sweden
Best Pract Res Clin Endocrinol Metab 22:601-13. 2008..One small placebo-controlled study showed no increase in incidence of prostate cancer after 6 months of testosterone therapy, but data on the safety of testosterone replacement therapy remain limited...
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancerPernilla Wikstrom
Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden
Prostate 51:268-75. 2002..In this study, endoglin was evaluated as a prognostic factor for prostate cancer progression...
Transrectal core biopsy trauma may increase cell proliferation in prostate tumorsA Bergh
Department of Pathology, Umea University, Umea, Sweden
Scand J Urol Nephrol 36:311-3. 2002..Further studies are needed to evaluate the clinical significance of this observation...
Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancerBjörn Anders Jonsson
Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden
Int J Cancer 98:838-43. 2002..In a family with hereditary gastric cancer of the diffuse type, we identified the first truncating germline mutation in a Scandinavian family...
Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancerP Stattin
Department of Urology and Andrology, , Sweden
Br J Cancer 77:670-5. 1998..These data suggest that it might be possible to predict the effect of castration therapy by examining tumour biopsies shortly after treatment...
Gonadotropin-releasing hormone receptor expression in the human prostateP Stattin
Institute of Surgical and Perioperative Sciences, Urology and Andrology, , , Sweden
Prostate 47:276-84. 2001..Comparative data show relatively high GnRH-R expression in human prostate tissue compared to other human tissues...
Castration-induced reduction of vascular endothelial growth factor expression in benign human prostate tissue is lost in advanced prostate cancerS Häggström
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
BJU Int 88:110-6. 2001....
